MRK - Merck & Co., Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Cash flows from operating activities
Net income
10,147,000
9,843,000
6,220,000
2,394,000
3,920,000
Depreciation & amortisation
3,575,000
3,652,000
4,519,000
4,637,000
5,441,000
Deferred income taxes
-668,000
-556,000
-509,000
-2,621,000
-1,521,000
Stock-based compensation
432,000
417,000
348,000
312,000
300,000
Change in working capital
-2,798,000
-2,067,000
-1,553,000
-5,021,000
-2,601,000
Accounts receivable
-
294,000
-418,000
297,000
-619,000
Inventory
-
-508,000
-911,000
-145,000
206,000
Accounts payable
-
399,000
230,000
254,000
278,000
Other working capital
8,947,000
9,967,000
8,307,000
4,559,000
8,762,000
Other non-cash items
1,200,000
1,177,000
1,628,000
769,000
938,000
Net cash provided by operating activities
12,811,000
13,440,000
10,922,000
6,447,000
10,376,000
Cash flows from investing activities
Investments in property, plant and equipment
-3,864,000
-3,473,000
-2,615,000
-1,888,000
-1,614,000
Acquisitions, net
-7,499,000
-4,954,000
-431,000
-396,000
-780,000
Purchases of investments
-2,277,000
-3,202,000
-7,994,000
-10,739,000
-15,651,000
Sales/maturities of investments
8,539,000
8,622,000
15,252,000
15,664,000
14,353,000
Other investing activities
476,000
378,000
102,000
38,000
482,000
Net cash used for investing activities
-4,625,000
-2,629,000
4,314,000
2,679,000
-3,210,000
Cash flows from financing activities
Debt repayment
-1,951,000
0
-4,287,000
-1,103,000
-2,386,000
Common stock repurchased
-4,971,000
-4,780,000
-9,091,000
-4,014,000
-3,434,000
Dividends paid
-5,818,000
-5,695,000
-5,172,000
-5,167,000
-5,124,000
Other financing activities
-219,000
5,000
-325,000
-195,000
-118,000
Net cash used provided by (used for) financing activities
-8,737,000
-8,861,000
-13,160,000
-10,006,000
-9,044,000
Net change in cash
-617,000
1,967,000
1,871,000
-423,000
-2,009,000
Cash at beginning of period
8,077,000
7,967,000
6,096,000
6,515,000
8,524,000
Cash at end of period
7,526,000
9,934,000
7,967,000
6,092,000
6,515,000
Free cash flow
Operating cash flow
12,811,000
13,440,000
10,922,000
6,447,000
10,376,000
Capital expenditure
-3,864,000
-3,473,000
-2,615,000
-1,888,000
-1,614,000
Free cash flow
8,947,000
9,967,000
8,307,000
4,559,000
8,762,000
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more